DG Capital Management (Massachusetts)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | $536K | Sell |
6,144
-2,980
| -33% | -$260K | 0.53% | 57 |
|
|
2016
Q2 | $785K | Buy |
9,124
+2,251
| +33% | +$194K | 0.84% | 52 |
|
|
2016
Q1 | $546K | Sell |
6,873
-900
| -12% | -$71.5K | 0.53% | 57 |
|
|
2015
Q4 | $978K | Sell |
7,773
-3,830
| -33% | -$482K | 0.87% | 46 |
|
|
2015
Q3 | $1.21M | Sell |
11,603
-1,820
| -14% | -$189K | 0.81% | 48 |
|
|
2015
Q2 | $1.66M | Sell |
13,423
-545
| -4% | -$67.3K | 1% | 49 |
|
|
2015
Q1 | $1.65M | Buy |
13,968
+8,215
| +143% | +$969K | 0.99% | 50 |
|
|
2014
Q4 | $683K | Sell |
5,753
-2,540
| -31% | -$302K | 0.4% | 60 |
|
|
2014
Q3 | $931K | Buy |
8,293
+3,203
| +63% | +$360K | 0.57% | 58 |
|
|
2014
Q2 | $482K | Sell |
5,090
-15,020
| -75% | -$1.42M | 0.27% | 58 |
|
|
2014
Q1 | $1.42M | Sell |
20,110
-8,215
| -29% | -$581K | 0.84% | 48 |
|
|
2013
Q4 | $2.11M | Sell |
28,325
-9,215
| -25% | -$685K | 1.17% | 44 |
|
|
2013
Q3 | $2.85M | Buy |
37,540
+2,500
| +7% | +$190K | 1.61% | 32 |
|
|
2013
Q2 | $2.81M | Buy |
+35,040
| New | +$2.81M | 1.7% | 29 |
|